Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET) Meeting Abstract
| Authors: | Hobday, T. J.; Qin, R.; Reidy, D. L.; Moore, M. J.; Strosberg, J. R.; Kaubisch, A.; Shah, M. H.; Kindler, H. L.; Lenz, H. J.; Chen, H. X.; Erlichman, C. |
| Abstract Title: | Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET) |
| Meeting Title: | 2012 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2012 Jan 19-21 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-02-01 |
| Language: | English |
| ACCESSION: | WOS:000209849300260 |
| DOI: | 10.1200/jco.2012.30.4_suppl.260 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 260 -- Source: Wos |
